Table 2.
Contributing factors to each endoscopic phenotype of the J pouch (multivariable analysis)
Phenotype | N | Variables | Odds ratio (95% CI) | P-value |
---|---|---|---|---|
Afferent limb involvement | 131 | BMI ≥ 25 | 1.84 (1.11–3.03) | 0.017 |
Hand-sewn anastomosis | 1.96 (1.15–3.33) | 0.013 | ||
Inlet involvement | 178 | Male | 1.58 (1.05–2.38) | 0.028 |
Age at diagnosis ≥ 18 years old | 0.58 (0.33–1.04) | 0.068 | ||
Age at colectomy ≥ 18 years old | 0.52 (0.22–1.21) | 0.13 | ||
Diffuse inflammation of the pouch body | 118 | Disease extent E3 | 2.40 (1.02–5.66) | 0.045 |
Preoperative anti-TNFα drugs | 1.79 (1.08–2.97) | 0.023 | ||
Family history of IBD | 0.67 (0.38–1.20) | 0.18 | ||
Age at diagnosis ≥ 18 years old | 0.62 (0.34–1.12) | 0.11 | ||
Male | 1.55 (0.92–2.61) | 0.10 | ||
Focal inflammation of the pouch body | 218 | Disease extent E3 | 0.52 (0.27–0.98) | 0.044 |
Age at diagnosis ≥ 18 years old | 1.40 (0.82–2.39) | 0.22 | ||
Preoperative immunomodulators | 1.39 (0.89–2.18) | 0.15 | ||
Cuffitis | 192 | Stapled anastomosis | 2.59 (1.28–5.22) | 0.008 |
Preoperative CDI | 2.06 (1.09–3.89) | 0.025 | ||
3-stage IPAA | 1.50 (0.83–2.70) | 0.18 | ||
Dysplasia/Cancer (Indication of surgery) | 0.78 (0.31–1.96) | 0.59 | ||
Preoperative anti-TNFα drugs | 1.42 (0.81–2.47) | 0.22 | ||
Caucasian | 0.46 (0.19–1.09) | 0.076 | ||
Male | 1.51 (0.90–2.51) | 0.12 | ||
Fistulas | 78 | Preoperative diagnosis of Crohn’s disease | 10.4 (1.81–60.0) | 0.009 |
Family history of IBD | 1.54 (0.90–2.64) | 0.12 | ||
Preoperative anti-TNFα drugs | 0.63 (0.37–1.07) | 0.085 |